The neuroleptic malignant syndrome.
The neuroleptic malignant syndrome is an uncommon, potentially fatal, adverse reaction to major tranquillisers. Prompt diagnosis, cessation of medication and supportive medical care are essential in management.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D003244:Consciousness Disorders / Q000139:chemically induced*; D005334:Fever / Q000139:chemically induced*; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000139:chemically induced*; D013577:Syndrome; D014202:Tremor / Q000139:chemically induced
D014150:Antipsychotic Agents; D005476:Fluphenazine